Methastyridone is a centrally acting stimulant, whose mode of action differs from that of classical agents such as d-amphetamine.[1][2][3]

Methastyridone
Clinical data
ATC code
  • none
Identifiers
  • 2,2-dimethyl-5-[(E)-2-phenylethenyl]-1,3-oxazolidin-4-one
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H15NO2
Molar mass217.268 g·mol−1
3D model (JSmol)
  • CC1(C)NC(=O)C(O1)\C=C\c2ccccc2
  • InChI=1S/C13H15NO2/c1-13(2)14-12(15)11(16-13)9-8-10-6-4-3-5-7-10/h3-9,11H,1-2H3,(H,14,15)/b9-8+
  • Key:VEZXEOWXHFHYHC-CMDGGOBGSA-N

References

edit
  1. ^ Dictionary of pharmacological agents. London: Chapman & Hall. 1997.
  2. ^ Kurkland AA, Arbona L, McCusker K (August 1961). "Clinical trial of methastyridone (MK-202) with chronic anergic schzophrenics". The Journal of Nervous and Mental Disease. 133 (2): 174–5. doi:10.1097/00005053-196108000-00015. PMID 14460735.
  3. ^ Rasmussen N (2008). On speed: the many lives of amphetamine. New York: New York University Press. pp. 154–155. ISBN 9780814776278.